Literature DB >> 3679679

An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy.

S C Manning1, D Beste, T McBride, A Goldberg.   

Abstract

Preoperative coagulation studies are commonly employed in order to try to identify the 2-4% of all patients undergoing tonsillectomy/adenoidectomy surgery who experience hemorrhagic complications. In an atmosphere of increasing cost consciousness, evaluation of the efficacy of screening tests is warranted. The records of 994 out of 1050 patients consecutively scheduled for tonsillectomy, adenoidectomy or T&A over a 2.5-year period were retrospectively reviewed in order to determine the usefulness of partial thromboplastin (PTT) and prothrombin time (PT) screening in predicting surgical and postsurgical bleeding. For patients with no history or clinical signs indicating possible bleeding disorder, preoperative PT and PTT failed to predict bleeding as an outcome. Also no patients were identified in this series to have previously undiagnosed coagulopathies on the basis of screening PT/PTT. The purpose of any screening test is to identify disease early enough for therapeutic intervention to be effective. Although preoperative PT/PTT will occasionally identify an unsuspected von Willebrand's or other coagulopathy, the prevalence of bleeding disorders in patients with negative history and examination is low enough that PT/PTT has essentially a zero predictive value for surgical bleeding. Screening PT/PTT should therefore be reserved for patients with known or suspected coagulopathies.

Entities:  

Mesh:

Year:  1987        PMID: 3679679     DOI: 10.1016/0165-5876(87)90104-2

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  10 in total

1.  Tonsillectomy in children.

Authors:  Boris A Stuck; Karl Götte; Jochen P Windfuhr; Harald Genzwürker; Horst Schroten; Tobias Tenenbaum
Journal:  Dtsch Arztebl Int       Date:  2008-12-05       Impact factor: 5.594

2.  Occurrence of coagulation factor deficiency in post-tonsillectomy hemorrhage.

Authors:  Michaela Zumtobel; Klemens Frei
Journal:  Wien Klin Wochenschr       Date:  2011-04-11       Impact factor: 1.704

Review 3.  [Perioperative coagulation diagnostics].

Authors:  C-E Dempfle
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

4.  Surgical revision of hemorrhage in 8388 patients after cold-steel adenotonsillectomies.

Authors:  Christoph Arnoldner; Matthäus Ch Grasl; Dietmar Thurnher; Jafar-Sasan Hamzavi; Alexandra Kaider; Markus Brunner; Boban M Erovic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 5.  [Tonsillectomy in children: preoperative evaluation of risk factors].

Authors:  B A Stuck; H V Genzwürker
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

6.  The value of routine preoperative testing in the prediction of operative hemorrhage in adenotonsillectomy.

Authors:  Galila Zaher; Khaled Al-Noury
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-08-27

Review 7.  Malpractice claims and unintentional outcome of tonsil surgery and other standard procedures in otorhinolaryngology.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 8.  Adenotonsillectomy in high risk patients: Hematologic abnormalities and COVID-19 considerations.

Authors:  Ryan Ruiz; Kavita Dedhia
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2021-05-29

9.  Our experience with pre-operative haemostatic assessment of paediatric patients undergoing adenotonsillectomy at Federal Medical Centre, Makurdi.

Authors:  Amali Adekwu; Agida Samuel Adoga; Terna Ambrose Gav
Journal:  Afr J Paediatr Surg       Date:  2016 Apr-Jun

10.  Risk Factors for Postoperative Bleeding after Adenoidectomy.

Authors:  Milan Urík; Michal Bartoš; Soňa Šikolová; Jana Jančíková; Klára Perceová; Jiří Jarkovský; Eva Klabusayová; Petr Štourač; Petr Jabandžiev
Journal:  Children (Basel)       Date:  2021-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.